MMedication Read More My Mother Had Alzheimer’s. That’s Why I Started a GLP-1July 15, 2026 As an endocrinologist, I spend much of my day discussing GLP-1 medications with my patients. This week, I…
MMedication Read More Most ‘GLP-1 Nonresponders’ Never Get a Fair ShotJuly 3, 2026 I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
MMedication Read More Nutrition matters for GLP-1 drug users June 25, 2026 We noticed it right away in 2005 when the first GLP-1 medication for people with diabetes hit the…
MMedication Read More Ozempic Weight Loss: From willpower to prescriptions: How Ozempic is rewriting the weight-loss storyJune 16, 2026 There is a moment, somewhere between a celebrity rumour and a viral before-and-after, when a drug stops being…
MMedication Read More Keeping rebound weight off after stopping GLP-1 drugsJune 6, 2026 For many, GLP-1 (glucagon-like peptide-1) drugs like tirzepatide and semaglutide offered an ideal solution to diabetes and weight…
MMedication Read More How GLP-1s are more than just weight-loss wonders – but not without riskMay 23, 2026 Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
MMedication Read More GLP-1 plus therapy can reduce heavy drinkingMay 12, 2026 May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…
MMedication Read More GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: StudyMay 6, 2026 Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny…
MMedication Read More New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight LossMay 4, 2026 Treatment for diabetes and obesity is rapidly evolving, with multi-targeted approaches taking shape. Medications like semaglutide, a glucagon-like…
MMedication Read More Should you take GLP-1 drugs for longevity?March 15, 2026 This is, indeed, part of a wider trend of mutual support at the fringes of pharmacology, with similar…
MMedication Read More Health Ministry warns against GLP-1 drug misuse, urges reporting of side effectsMarch 7, 2026 THE Health Ministry has acknowledged growing public concern over the off-label use of GLP-1 receptor agonists, especially for…
MMedication Read More Weight loss jab users warned they could be ‘worse off than before’March 5, 2026 Wegovy and Mounjaro are approved by the NHS for weight loss use (Image: OMaltseva via Getty Images) People…